Luz Saude Valuation, Funding & Investors

Luz Saude is valued at $3.2B as of September 2025.

Last Luz Saude valuation

$3.2B

Secondary · Sep 2025

Key investors in Luz Saude

  • Macquarie Asset Management

Luz Saude Overview

About Luz Saude

Luz Saúde is a Lisbon-headquartered healthcare group operating eleven private hospitals, one public-private partnership hospital, ten outpatient clinics, and two senior residences across northern, central, and southern mainland Portugal plus Madeira. Established in 2000, the company listed on Euronext Lisbon in 2014 with Fidelidade as majority shareholder holding over 98 percent of shares. Luz Saúde manages integrated care networks including orthopedic, oncology, and maternity services.


Founded

2000

HQ

PortugalLisbon

Status

Privately held

Customer focus

B2C

Revenue model

Services

Valuation

$3.2B (Sep 2025)

Luz Saude Valuation

Luz Saude is currently valued at $3.2B, based on its secondary sale in September 2025.

The $364M round was led by Macquarie Asset Management.

Luz Saude valuation by funding round

Luz Saude valuation by funding round
DateStageValuation
Sep 2025Secondary$3.2B

Luz Saude Funding History

Luz Saude has 1 recorded secondary share sale and no primary funding rounds.

Luz Saude funding rounds

Luz Saude funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Sep 2025SecondaryMacquarie Asset Management (lead)$364M$3.2BLuz Saúde is Portugal's leading private healthcare provider, operating 14 private hospitals, 15 outpatient clinics, and one senior residential facility across the country. The group delivers specialized clinical services across more than 65 medical specialties with a team of over 5,300 healthcare professionals. Macquarie Asset Management, through its Macquarie European Infrastructure Fund 7, acquired a 40% stake in Luz Saúde for €310 million in September 2025, with the transaction implying a total enterprise value of €1.1 billion. Fidelidade, Portugal's leading insurance company, retained the remaining 60% stake. The deal valued Luz Saúde at a 9.5x multiple of the group's 2024 EBITDA, reflecting strong market confidence in the company's stable cash flows from healthcare infrastructure. This investment marks Macquarie's strategic entry into the Portuguese private healthcare market, supporting the group's growth, digitalization, and technology initiatives including AI diagnostics. The transaction reflects broader institutional investor interest in European private healthcare driven by aging demographics, strained public health systems, and growing demand for high-quality care services.

Who has invested in Luz Saude?

1 investor has backed Luz Saude across its funding rounds, including Macquarie Asset Management.

Lead investors include Macquarie Asset Management.


Luz Saude Investors

Investors in Luz Saude by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 1 Luz Saude investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Luz Saude

Luz Saude has acquired 2 companies to date.

Last acquisition by Luz Saude was on July 10th 2017. Luz Saude acquired British Hospital Lisbon for undisclosed valuation.


Latest Acquisitions by Luz Saude

British Hospital Lisbon
Clihotel de Gaia
Description
British Hospital Lisbon is a Lisbon-based private healthcare provider operating a network of clinics and hospitals in Portugal. It specializes in cardiology, orthopedics, and oncology services for expatriates and international patients, with facilities equipped for elective surgeries and diagnostics.
Clihotel de Gaia functions as a healthcare facility in Vila Nova de Gaia, Portugal. The hospital provides inpatient care, outpatient consultations, maternity services, and surgical interventions across specialties like cardiology, orthopedics, and oncology. Equipped with intensive care units and diagnostic labs, it serves the Porto metropolitan area with round-the-clock emergency departments. Vila Nova de Gaia-based, Clihotel integrates advanced imaging and rehabilitation centers to support patient recovery.
HQ CountryPortugalPortugal
HQ City
Lisbon
Porto
Deal Date10 Jul 201720 Jan 2016
Valuationundisclosed$8M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Luz Saude acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Luz Saude

Luz Saude has invested in 1 company to date.

Latest investment by Luz Saude was on March 18th 2024. Luz Saude invested in UpHill in their $8M Series A round.


Latest Investments by Luz Saude

UpHill
Description
UpHill is an Europe-based digital health company providing clinical pathway software that integrates with hospital systems to automate workflows and track patient progress. Partnerships with leading healthcare and life sciences firms aim to cut care variability, enhancing outcomes and revenues.
HQ CountryPortugal
HQ City
Lisbon
Deal Date18 Mar 2024
RoundSeries A
Raised$8M
InvestorsRedstone.VC; MSM; Brighteye Ventures; Explorer Investments; SCR S.A.; Caixa Capital
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Luz Saude investments and their VC round multiples.

Start Free Trial

Luz Saude Competitors

Luz Saude competitors include listed companies like Aveanna Healthcare, IKS Health, Krishna Institute and Mouwasat, and private ones like Metro Pacific Hospital Holdings and Fosun Health.

Public and private companies comparable to Luz Saude
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Aveanna HealthcareUnited StatesUnited StatesPublicly listed$2.4B$269M$3B1.7x
IKS HealthIndiaIndiaPublicly listed$333M$113M$3B7.4x
Krishna InstituteIndiaIndiaPublicly listed$404M$84M$3.4B8.2x
MouwasatSaudi ArabiaSaudi ArabiaPublicly listed$859M$300M$3.5B4.1x
Metro Pacific Hospital HoldingsPhilippinesManilaPrivate--$1.6B-
Fosun HealthChinaShanghaiPrivate$913M-$1.5B1.6x
Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Aveanna Healthcare$2.4B$269M1.8x1.7x16.5x12.6x
IKS Health$333M$113M9.1x7.4x26.9x23.4x
Krishna Institute$404M$84M9.5x8.2x45.9x39.2x
Mouwasat$859M$300M4.4x4.1x12.6x12.6x
Guardian Pharmacy Service$1.4B$96M1.9x1.9x29.2x22.4x
National Healthcare Corp$1.5B$204M2.2x-16.4x-
Kpj Healthcare$1B$256M3.4x3.2x13.8x13.3x
Brookdale Senior Living$3.2B$332M2.5x2.6x23.7x16.0x

This data is available for Pro users. Sign up to see all Luz Saude competitors and their valuation data.

Start Free Trial

Common questions about Luz Saude

When was Luz Saude founded?Luz Saude was founded in 2000.
Where is Luz Saude headquartered?Luz Saude is headquartered in Lisbon, Portugal.
Is Luz Saude publicly listed?No, Luz Saude is a private, VC-backed company.
What is Luz Saude's valuation?Luz Saude was last valued at $3.2B in its secondary sale in September 2025.
Who are Luz Saude's investors?Luz Saude's investors include Macquarie Asset Management.
Which companies are comparable to Luz Saude?Companies comparable to Luz Saude include Aveanna Healthcare, IKS Health, Krishna Institute, Mouwasat, Metro Pacific Hospital Holdings and Fosun Health.
How many companies has Luz Saude acquired?Luz Saude has acquired 2 companies, including British Hospital Lisbon and Clihotel de Gaia.
What was the largest acquisition by Luz Saude?The $8M acquisition of Clihotel de Gaia in January 2016 is the largest acquisition Luz Saude has made to date.
How many companies has Luz Saude invested in?Luz Saude has invested in 1 company, including UpHill.
What was Luz Saude's last investment?In March 2024, Luz Saude invested in UpHill's $8M Series A alongside Redstone.VC, MSM, Brighteye Ventures and 3 other investors.

See companies similar to Luz Saude

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial